Join us for our webinar 'Learning from the masters: Preeclampsia and Ultrasound'. This free 2-hour long webinar on Wednesday 01 of October will feature an international panel of experts in ultrasound.
This webinar will take place on Wednesday 01 October 2025, led by Prof.Liona Poon and Prof. Daniel Rolnik and sponsored by Samsung.
This course is relevant to obstetricians, sonographers, general practitioners and anyone involved in ultrasound.
This webinar is available to watch on-demand.
This course is free to attend and aimed at anyone who wants to increase their knowledge and understanding in the use of ultrasound and pre-eclampsia.
Learning outcomes:
• Understand how we can predict and help prevent pre-eclampsia and other problems during
pregnancy.
• Explain how pre-eclampsia and high blood pressure in pregnancy can affect the baby’s growth.
• Describe how pregnancy affects a mother’s heart and blood vessels during and after pregnancy.
• Understand the long-term effects on heart health for women who had pre-eclampsia in
pregnancy.
Date: 1st October 2025
Time: 12:00 - 14:00 BST (UTC+1)
Start time in different time zones
| New York | London | Berlin | India | Beijing | Sydney | Brazil |
| 07:00 | 12:00 | 13:00 | 16:30 | 19:00 | 21:00 | 08:00 |
Please check a world clock website for your own time, for example: https://www.timeanddate.com/
Executive Committee, Finance & Risk Committee, Nominations Committee, China Task Force, UOG Editorial Board
Professor Liona Poon is an Academic Subspecialist in Maternal Fetal Medicine, devoted in improving maternal and fetal health. She has had a prolific research output throughout her clinical and research posts, including over 130 peer-reviewed publications in high impact international journals. In the last 10 years she has focused her research on establishing a programme for effective early prediction and prevention of preeclampsia, a major cause of maternal and perinatal morbidity and mortality. With her success in developing a first-trimester prediction model for preeclampsia using maternal risk factors, ultrasound, blood pressure and biochemical markers, and on Aspirin prophylaxis against preeclampsia, her goal in the next 10 years is to improve obstetric care worldwide, through clinical research and education.
Notable Publications:
Aspire trial: incidence of preterm preeclampsia in patients fulfulling ACOG and NICE criteria according to risk by the FMF algorithm. Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nikolaides KH.
Ultrasound Obstet Gynecol 2018 Jan 30. doi: 10.1002/uog.19019 [Epub ahead of print]
Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides K.H.
New England Journal Medicine 2017, 2017 Jun 28. doi: 10.1056/NEJMoa1704559. [Epub ahead of print]
Country: China, Hong Kong Special Administrative Region
Field: Obstetrics
Specialties: Fetal anomaly screening 1st trimester and 2nd trimester; fetal biometry and wellbeing; fetal anomalies screening; aneuploidy screening; fetal anomalies; fetal growth restriction; maternal and fetal Doppler; multiple pregnancy; preeclampsia; preterm delivery; fetal growth; detection of fetal and neonatal growth abnormalities; ultrasound on the labour ward
Languages: English; Chinese (Mandarin); Chinese (Cantonese)
Prof Daniel Rolnik completed his Obstetrics and Gynaecology training and was awarded a Master’s degree at the University of São Paulo, Brazil.
He then went on to work with Professor Kypros Nicolaides at King’s College Hospital and Fetal Medicine Foundation in London, and undertook the Diploma in Fetal Medicine and his PhD. Daniel led the ASPRE trial, a large-scale randomised trial investigating the role of low-dose aspirin in preventing preeclampsia in the context of a large first-trimester screening program. He has published over 175 peer-reviewed scientific papers.
Daniel currently works as a Consultant in Obstetrics and Gynaecology and Director of the Perinatal Care Centre at Monash Health and is an Associate Professor at Monash University, Melbourne, Australia.
He was recently awarded a Master of Public Health degree in Epidemiology at Harvard University, USA, and received The Australian 2023 Top O&G Researcher award.
This webinar is proudly sponsored by SAMSUNG.
